Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novo Nordisk ADR | NVO | Nov 19, 2024 | 102.63 | +2.83 |
NovoCure | NVCR | Nov 19, 2024 | 16.48 | +4.77 |
Novonix ADR | NVX | Nov 19, 2024 | 2.05 | -2.84 |
NRG Energy | NRG | Nov 19, 2024 | 94.86 | +1.75 |
NRx Pharmaceuticals | NRXP | Nov 19, 2024 | 1.23 | -5.77 |
NSTS Bancorp | NSTS | Nov 19, 2024 | 11.20 | +0.90 |
Nu Holdings | NU | Nov 19, 2024 | 13.46 | -1.39 |
Nu Skin Enterprises | NUS | Nov 19, 2024 | 7.59 | -2.82 |
Nuburu | BURU | Nov 19, 2024 | 0.48 | +12.30 |
NuCana ADR | NCNA | Nov 19, 2024 | 1.33 | -7.64 |
Nucor | NUE | Nov 19, 2024 | 144.68 | -1.75 |
Nukkleus | NUKK | Nov 19, 2024 | 1.75 | +8.70 |
Nurix Therapeutics | NRIX | Nov 19, 2024 | 22.79 | +4.59 |
NuScale Power | SMR | Nov 19, 2024 | 27.02 | -0.92 |
Nustar Energy C Pref | NS-C | Nov 19, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 19, 2024 | 68.44 | -0.16 |
Nutex Health | NUTX | Nov 19, 2024 | 28.78 | +2.42 |
Nutriband | NTRB | Nov 19, 2024 | 4.91 | -1.01 |
Nutrien | NTR | Nov 19, 2024 | 45.56 | -0.09 |
Nuvalent A | NUVL | Nov 19, 2024 | 91.06 | +3.84 |
Nuvation Bio A | NUVB | Nov 19, 2024 | 2.59 | +1.17 |
Nuvectis Pharma | NVCT | Nov 19, 2024 | 5.14 | +1.98 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 19, 2024 | 12.84 | +0.39 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 19, 2024 | 13.75 | -0.29 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 19, 2024 | 11.59 | +0.43 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 19, 2024 | 11.95 | -0.33 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Nov 19, 2024 | 12.93 | -0.23 |
Nuveen California Municipal Value Fund | NCA | Nov 19, 2024 | 8.65 | -0.23 |
Nuveen California Quality Municipal Income Fund | NAC | Nov 19, 2024 | 11.34 | -0.61 |
Nuveen California Select Taxfree Income Portfolio | NXC | Nov 19, 2024 | 13.31 | +0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.